Invention Grant
- Patent Title: Formulation
-
Application No.: US16478232Application Date: 2018-01-25
-
Publication No.: US11590243B2Publication Date: 2023-02-28
- Inventor: Erwan Bourles , Olivier Despas , Delphine Guillaume , Frederic Mathot , Mathieu Vasselle
- Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: GB1701239 20170125
- International Application: PCT/IB2018/050453 WO 20180125
- International Announcement: WO2018/138667 WO 20180802
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K48/00 ; A61K9/00 ; A61K9/08 ; A61K9/19 ; A61K47/02 ; A61K47/26 ; C12N15/86
Abstract:
The present invention relates to the formulation of adenoviral vectors in sorbitol containing compositions in combination with a further amorphous sugar, its formulation as well as a method for obtaining a dried composition.
Information query
